Simply inject fewer units from the prefilled syringe
Suppressing ferroptosis has demonstrated the potential to slow the progression of various diseases, such as ischemia-reperfusion injury, ischemic cardiomyopathy, neurodegenerative diseases, organ transplant rejection, kidney damage and renal fibrosis [24]
(2000): The potential role of fatty acids in attention-deficit/hyperactivity disorder
Optimising meal timing is particularly important given Wegovy's effect on gastric emptying
This suggests that further research, especially well-designed, long-term clinical trials, may be warranted
Technical details are summarized in the FDA prescribing information and independent overviews such as StatPearls (both describe the ~1-week half-life and slow elimination)